National Weekly Bulletin

Year: Week:

NATIONAL WEEKLY INFLUENZA BULLETIN OF THE RUSSIAN FEDERATION

week 45 of 2022 (07.11.22 - 13.11.22)

Summary

Influenza and ARI incidence data. Influenza and other ARI activity increase of influenza and other ARI activity in Russia in comparison with previous week. The nationwide ILI and ARI morbidity level (71.3 per 10 000 of population) was higher than national baseline (70.0) by 1.9%.

Etiology of ILI & ARI. Among 3751 patients investigation 39 (1.0%) respiratory samples were positive for influenza, including 26 cases of influenza A(H1N1)pdm09 in 10 cities and 13 cases of influenza B in 3 cities.

2 influenza A(H1N1)pdm09 viruses were isolated on MDCK cell culture, including: in Moscow (1) and Saint-Petersburg (1).  

Antigenic characterization. Since the beginning of the season, 1 influenza A(H1N1)pdm09 has been antigenically characterized by the NICs (Moscow). Virus was antigenically similar to reference strain A/Victoria/2570/2019 (H1N1)pdm09. 

ARVI detections. The overall proportion of respiratory samples tested positive for other ARVI (PIV, ADV, RSV, RhV, CoV, MPV, BoV) was estimated in total as 27.8% (PCR).

In sentinel surveillance system clinical samples from 49 SARI patients were investigated by rRT-PCR for influenza, among them no positive cases recognized. 39 SARI patients were investigated for ARVI by rRT-PCR, among them 15 (38.5%) cases of ARVI recognized including 1 case of PIV, 3 cases of ADV, 1 case of RSV, 4 cases of RhV, 2 cases of CoV and 4 cases of BoV infection. 3 (6.8%) of 44 SARI patients were positive for coronavirus SARS-CoV-2.

Clinical samples from 26 ILI/ARI patients were investigated for influenza by rRT-PCR, among them no positive cases recognized. Among 21 ILI/ARI samples 4 (19.0%) cases positive for ARVI detected including 2 cases of ADV infection and 2 cases of RhV. 26 ILI/ARI patients were investigated for SARS-CoV-2 by rRT-PCR, among them no positive cases recognized. 

COVID-19. Totally 21 514 341 cases and 391 212 deaths associated with COVID-19 were registered in Russia including 5 380 cases and 63 deaths in last 24 hours (on 12:00 of 16.11.2022). According to the data obtained by NIC in Saint-Petersburg totally 9 392 clinical samples were PCR investigated in last week. Among them coronavirus SARS-CoV-2 detected in 560 (6.0%) cases.

Influenza and ARI morbidity data

Fig. 1. Influenza and ARVI morbidity in 61 cities under surveillance in Russia, seasons 2021/22 and 2022/23
Rates per 10 000 populationFig. 1. Influenza and ARVI morbidity in 61 cities under surveillance in Russia, seasons 2021/22 and 2022/23

Weeks

  • Morbidity 2022/23Morbidity 2022/23
  • Morbidity 2021/22Morbidity 2021/22
  • MEM baseline 2022/23MEM baseline 2022/23

Epidemiological data showed increase of influenza and other ARI activity in Russia in comparison with previous week. The nationwide ILI and ARI morbidity level (71.3 per 10 000 of population) was higher than national baseline (70.0) by 1.9%.

Fig. 2. Comparative data on incidence rate of clinically diagnosed influenza, seasons 2021/22 and 2022/23
Rates per 10 000 populationFig. 2. Comparative data on incidence rate of clinically diagnosed influenza, seasons 2021/22 and 2022/23

Weeks

  • Season 2022/23Season 2022/23
  • Season 2021/22Season 2021/22
  • MEM baselineMEM baseline

Incidence rate of clinically diagnosed influenza increased comparing to previous week and amounted to 0.081 per 10 000 of population, it was higer than pre-epidemic MEM baseline (0.060).

Fig. 3. Comparison of hospitalization rate with clinical diagnosis of influenza, seasons 2021/22 and 2022/23
Rates per 10 000 populationFig. 3. Comparison of hospitalization rate with clinical diagnosis of influenza, seasons 2021/22 and 2022/23

Weeks

  • Season 2022/23Season 2022/23
  • Season 2021/22Season 2021/22
  • MEM baselineMEM baseline

Hospitalization rate of clinically diagnosed influenza decreased comparing to previous week and amounted to 0.023 per 10 000 of population, it was lower than pre-epidemic MEM baseline (0.040).

Influenza and ARVI laboratory testing results

Cumulative results of influenza laboratory diagnosis by rRT-PCR were submitted by 45 RBLs and two WHO NICs. According to these data as a result of 3751 patients investigation 39 (1.0%) respiratory samples were positive for influenza, including 26 cases of influenza A(H1N1)pdm09 in 10 cities and 13 cases of influenza B in 3 cities.

2 influenza A(H1N1)pdm09 viruses were isolated on MDCK cell culture, including: in Moscow (1) and Saint-Petersburg (1).

Antigenic characterization. Since the beginning of the season, 1 influenza A(H1N1)pdm09 has been antigenically characterized by the NICs (Moscow). Virus was antigenically similar to reference strain A/Victoria/2570/2019 (H1N1)pdm09.

Fig. 4. Geographic distribution of RT-PCR detected influenza viruses in cities under surveillance in Russia, week 45 of 2022
Fig. 4. Geographic distribution of RT-PCR detected influenza viruses in cities under surveillance in Russia, week 45 of 2022
PCR results
  • No dataNo data
  • No viruses detectedNo viruses detected
  • H1pdm09H1pdm09
  • H3H3
  • H3+H1pdm09H3+H1pdm09
  • BB
  • B+H1pdm09B+H1pdm09
  • B+H3B+H3
  • B+H3+H1pdm09B+H3+H1pdm09
  • A (not subt.)A (not subt.)
  • A (not subt.)+H1pdm09A (not subt.)+H1pdm09
  • A (not subt.)+H3A (not subt.)+H3
  • A (not subt.)+H3+H1pdm09A (not subt.)+H3+H1pdm09
  • A (not subt.)+BA (not subt.)+B
  • A (not subt.)+B+H1pdm09A (not subt.)+B+H1pdm09
  • A (not subt.)+B+H3A (not subt.)+B+H3
  • A (not subt.)+B+H3+H1pdm09A (not subt.)+B+H3+H1pdm09
Fig. 5. Monitoring of influenza viruses detection by RT-PCR in Russia, season 2022/23
Number of positive casesFig. 5. Monitoring of influenza viruses detection by RT-PCR in Russia, season 2022/23% positive

Weeks

  • H1pdm09H1pdm09
  • H3H3
  • BB
  • A (not subt.)A (not subt.)
  • % positive% positive
Fig. 6. Monitoring of ARVI detection by RT-PCR in Russia, season 2022/23
Number of positive casesFig. 6. Monitoring of ARVI detection by RT-PCR in Russia, season 2022/23

Weeks

  • PIVPIV
  • ADVADV
  • RSVRSV
  • RhVRhV
  • CoVCoV
  • MPVMPV
  • BoVBoV

ARVI detections. The overall proportion of respiratory samples tested positive for other ARVI (PIV, ADV, RSV, RhV, CoV, MPV, BoV) estimated as 27.8% of investigated samples by PCR.

Fig. 7. Monitoring of influenza viruses isolation in Russia, season 2022/23
Number of positive casesFig. 7. Monitoring of influenza viruses isolation in Russia, season 2022/23% positive

Weeks

  • H1pdm09H1pdm09
  • H3H3
  • BB
  • % positive% positive

Table 1. Results of influenza and other ARVI detection by RT-PCR in Russia, week 45 of 2022

  Number of  specimens / number of positive cases  % positive
Influenza
Number of specimens tested for influenza 3831 -
Influenza A (not subt.) 0 0,0%
Influenza A(H1)pdm09 37 1,0% 
Influenza A(H3) 0 0,0% 
Influenza B 13 0,3% 
All influenza 50 1,3%
Other ARVI
Number of specimens tested for ARVI 3380  -
PIV 80 2,4%
ADV 93 2,8%
RSV 187 5,5%
RhV 314 9,3%
CoV 47 1,4%
MPV 142 4,2%
BoV 60 1,8%
All ARVI 923 27,3%
SARS-CoV-2 (COVID-19)
Number of specimens tested for SARS-CoV-2 9472 -
SARS-CoV-2 561 5,9%
Fig. 8. Results of PCR detections of SARS-CoV-2 in Russia
Fig. 8. Results of PCR detections of SARS-CoV-2 in Russia
% positive
  • No dataNo data
  • less then 10%less then 10%
  • 10-20%10-20%
  • 20-30%20-30%
  • 30-40%30-40%
  • 40-50%40-50%
  • 50% and more50% and more

COVID-19. Totally 21 514 341 cases and 391 212 deaths associated with COVID-19 were registered in Russia including 5 380 cases and 63 deaths in last 24 hours (on 12:00 of 16.11.2022). According to the data obtained by NIC in Saint-Petersburg totally 9 392 clinical samples were PCR investigated in last week. Among them coronavirus SARS-CoV-2 detected in 560 (6.0%) cases.

Table 2. Results of influenza viruses isolation in Russia, week 45 of 2022

  Number of specimens / number of viruses  % isolated viruses
Number of specimens 18 -
Influenza A(H1)pdm09 2 11,1% 
Influenza A(H3) 0 0,0% 
Influenza B 0 0,0% 
All influenza 2 11,1%

Sentinel influenza surveillance

Clinical samples from 49 SARI patients were investigated by rRT-PCR for influenza, among them no positive cases recognized. 39 SARI patients were investigated for ARVI by rRT-PCR, among them 15 (38.5%) cases of ARVI recognized including 1 case of PIV, 3 cases of ADV, 1 case of RSV, 4 cases of RhV, 2 cases of CoV and 4 cases of BoV infection. 3 (6.8%) of 44 SARI patients were positive for coronavirus SARS-CoV-2.

Clinical samples from 26 ILI/ARI patients were investigated for influenza by rRT-PCR, among them no positive cases recognized. Among 21 ILI/ARI samples 4 (19.0%) cases positive for ARVI detected including 2 cases of ADV infection and 2 cases of RhV. 26 ILI/ARI patients were investigated for SARS-CoV-2 by rRT-PCR, among them no positive cases recognized.

Fig. 9. Monitoring of influenza viruses detection by RT-PCR among SARI patients in sentinel hospitals, season 2022/23
Number of positive casesFig. 9.  Monitoring of influenza viruses detection by RT-PCR among SARI patients in sentinel hospitals, season 2022/23% positive

Weeks

  • H1pdm09H1pdm09
  • H3H3
  • BB
  • A (not subt.)A (not subt.)
  • % positive% positive
Fig. 10. Monitoring of influenza viruses detection by RT-PCR among ILI/ARI patients in sentinel polyclinics, season 2022/23
Number of positive casesFig. 10.  Monitoring of influenza viruses detection by RT-PCR among ILI/ARI patients in sentinel polyclinics, season 2022/23% positive

Weeks

  • H1pdm09H1pdm09
  • H3H3
  • BB
  • A (not subt.)A (not subt.)
  • % positive% positive
Fig. 11. Monitoring of ARVI detection by RT-PCR among SARI patients in sentinel hospitals, season 2022/23
Number of positive casesFig. 11.  Monitoring of ARVI detection by RT-PCR among SARI patients in sentinel hospitals, season 2022/23

Weeks

  • PIVPIV
  • ADVADV
  • RSVRSV
  • RhVRhV
  • CoVCoV
  • MPVMPV
  • BoVBoV
Fig. 12. Monitoring of ARVI detection by RT-PCR among ILI/ARI patients in sentinel polyclinics, season 2022/23
Number of positive casesFig. 12.  Monitoring of ARVI detection by RT-PCR among ILI/ARI patients in sentinel polyclinics, season 2022/23

Weeks

  • PIVPIV
  • ADVADV
  • RSVRSV
  • RhVRhV
  • CoVCoV
  • MPVMPV
  • BoVBoV
Download PDF version